Over 80% of patients with COVID-19 experience lymphopenia and exhibit drastically reduced numbers of various lymphocyte subsets, including CD4+ T, CD8+ T, B, γδ T, and NK cells, especially in the peripheral blood of those with severe COVID-19 during the acute phase (16, 30, –, 34). This evidence concerns the gene CD4 and lymphopenia.